2200 Powell Street
Suite 310
Emeryville, CA 94608
United States
510 204 7200
https://www.xoma.com
Secteur(s):
Secteur d’activité:
Employés à temps plein: 13
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Owen P. Hughes Jr. | CEO & Director | 193,75k | S.O. | 1975 |
Mr. Thomas M. Burns | Senior VP of Finance & CFO | 759,24k | S.O. | 1974 |
Mr. Brad Sitko | Chief Investment Officer | 867,08k | S.O. | 1981 |
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
L’ISS Governance QualityScore de XOMA Corporation en date du 29 avril 2024 est 5. Les scores principaux sont Audit : 7; Société : 5; Droits des actionnaires : 2; Compensation : 7.